Work

A phase I dose expansion cohort study of dasatinib in combination with bevacizumab in advanced solid tumors (NCT01445509).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.2585

Authors: Akosua Osei-Tutu, Ana Tablante Nunes, Jung-min Lee, Minshu Yu, Lidia Hernandez, Helen X. Chen, Naoko Takebe, Nicole D. Houston, Irene Ekwede, Seth M. Steinberg, Jin-Qiu Chen, Liang Cao, W. Douglas Figg, Donna Butcher, Christina M. Annunziata, Elise C. Kohn

Institutions: National Cancer Institute, National Institutes of Health, Center for Cancer Research, Frederick National Laboratory for Cancer Research

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2778817744

Cites:

Cited by:

Related to: 10